Korean government touts M&A as fastest pharma route into China
This article was originally published in Scrip
Executive Summary
Amid the South Korean government's recent drive to encourage pharma firms to shift their focus to overseas markets, an official at the country's state-owned health industry institute has suggested the industry should seek mergers and acquisitions or joint ventures to advance into the rapidly growing Chinese pharma market.